SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Portugal In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018

[March 11, 2013]

Research and Markets: Portugal In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/bpm225/portugal_in_vitro) has announced the addition of Global Markets Direct's new report "Portugal In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018" to their offering.

Global Markets Direct's new report, Portugal In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018 provides key market data on the Portugal In Vitro Diagnostics market. The report provides value (USD) million data for each segment and sub-segment within seven market categories - Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology and Genetic Testing. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporae-level profiles of the key market participants with information on company financials and pipeline products, wherever available.


Scope

- Market size and company share data for In Vitro Diagnostics market categories - Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology and Genetic Testing.

- Annualized market revenues (USD million) data for each of the segments and sub-segments within seven market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the twelve market categories.

- Global corporate-level profiles of key companies operating within the Portugal In Vitro Diagnostics market.

- Key players covered include F. Hoffmann-La Roche Ltd., Siemens (News - Alert) Healthcare, Abbott Laboratories, bioMerieux S.A., Ortho-Clinical Diagnostics Inc., Beckman Coulter, Inc. and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Portugal In Vitro Diagnostics competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

For more information visit http://www.researchandmarkets.com/research/bpm225/portugal_in_vitro

Source (News - Alert): Global Markets Direct


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2013 Technology Marketing Corporation. All rights reserved.